Zai Lab Ltd
Zai Lab Ltd is a biopharmaceutical company focused on developing innovative medicines for cancer and other diseases.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Zai Lab's stock as its target price suggests significant value increase.
Financial Health
Zai Lab is performing well with strong revenue and cash flow, indicating healthy financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring ZLAB
China's Biopharma Innovators: The Next Global Partnership Wave
Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.
Published: July 28, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Catalysts
Clinical trial readouts and regulatory filings can drive material share-price moves, though outcomes can be binary and unpredictable.
Global Partnerships
Collaborations with larger pharma can broaden commercial reach and provide non‑dilutive funding, but depend on successful development and market access.
R&D Intensity
Heavy reinvestment into research is needed to advance candidates, offering upside if trials succeed and creating cash-burn risk if they do not.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
